Soleno Therapeutics Profit Margin

As of the most recent data (March 2026), SLNO shows a profit margin of 33.7%. That is above the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average profit margin is about 21.34%. Soleno Therapeutics is at 33.7%, which is higher that average. That is roughly 57.9% above the sector mean. Use the comparison chart on this page to see how SLNO stacks up against individual peers as well.

Check the historical chart to see whether SLNO's profit margin is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Soleno Therapeutics with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Soleno Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 33.7%) with ownership activity and broader fundamentals.

The Healthcare average profit margin is about 21.34%, while SLNO is at 33.7%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.